➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
McKesson
Colorcon
Johnson and Johnson
Mallinckrodt

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Patent: 7,151,114

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,151,114
Title:Use of substituted 2-phenylbenzimidazoles as medicaments
Abstract: The present invention relates to the use of a substituted 2-phenylbenzimidazole of formula I ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and m have the meanings given in the claims, for the preparation of a medicament for the treatment or prevention of diseases involving glucagon receptors, as well as new compounds of formula I wherein R.sup.1 is a group of formula ##STR00002##
Inventor(s): Streicher; Ruediger (Biberach, DE), Mack; Juergen (Biberach, DE), Walter; Rainer (Biberach, DE), Konetzki; Ingo (Warthausen, DE), Trieselmann; Thomas (Warthausen, DE), Austel; Volkhard (Biberach, DE)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim, DE)
Application Number:10/744,830
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,151,114
Patent Claims:see list of patent claims

Details for Patent 7,151,114

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02   Start Trial Boehringer Ingelheim International GmbH (Ingelheim, DE) 2023-01-09 RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Start Trial Boehringer Ingelheim International GmbH (Ingelheim, DE) 2023-01-09 RX Orphan search
Eisai Inc ONTAK denileukin diftitox VIAL 103767 001 1999-02-05   Start Trial Boehringer Ingelheim International GmbH (Ingelheim, DE) 2023-01-09 RX Orphan search
Pharmacia SOMAVERT pegvisomant INJECTABLE;SUBCUTANEOUS 021106 005 2003-03-25   Start Trial Boehringer Ingelheim International GmbH (Ingelheim, DE) 2023-01-09 RX search
Pharmacia SOMAVERT pegvisomant INJECTABLE;SUBCUTANEOUS 021106 004 2003-03-25   Start Trial Boehringer Ingelheim International GmbH (Ingelheim, DE) 2023-01-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Baxter
AstraZeneca
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.